• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Advances in Drug Resistance Research

Advances in Drug Resistance Research

9781631171314
900,84 zł
810,75 zł Zniżka 90,09 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 810,75 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Drug resistance continues to be a major problem in the effective treatment of many diseases. Resistance to chemotherapy, whether intrinsic or extrinsic, is the result of at least three well defined mechanisms:: prevention of the interaction of drug with the target, decreased intracellular concentration of the drug due to an increased efflux or a decreased influx, and enzymatic modification or destruction of the drug. With the advancement in technology, the molecular mechanisms of drug resistance have been unravelling at a rapid rate. This book is a timely review of such advances in drug resistance research. The nine chapters of this book, written by a group of clinicians and scientists, elegantly summarises recent advances in our understanding of this important clinical problem with emphasis on cisplatin, fibroblasts, natural compounds, erythropoiesis-stimulating agents, prostate cancer and kidney cancer. This book will be an important contribution to science, and an invaluable tool for researchers who are interested in drug resistance.
Szczegóły produktu
74491
9781631171314
9781631171314

Opis

Rok wydania
2014
Numer wydania
1
Oprawa
twarda
Liczba stron
220
Wymiary (mm)
155.00 x 230.00
Waga (g)
520
  • Mechanisms of Cisplatin Resistance:: DNA Repair & Cellular Implications; Multi-Drug Resistance in Cancer & New Approaches for its Overcoming; Tumor Fibroblasts:: Pivotal Players in Drug Resistance; Erythropoiesis Stimulating Agent Resistance; Therapeutic Options for Metastatic Castration Resistant Prostate Cancer:: Has the Situation Improved?; Current Trends in Prostate Cancer Treatment & Drug Resistance; Resistance of Metastatic Renal Cell Carcinomas to Chemo & Immunotherapy:: Clinicians Perspective; Resistance of Renal Cell Carcinoma to Targeted Therapy; Molecular Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma.
Komentarze (0)